Literature DB >> 9210450

Sensitive determination of docetaxel in human plasma by liquid-liquid extraction and reversed-phase high-performance liquid chromatography.

W J Loos1, J Verweij, K Nooter, G Stoter, A Sparreboom.   

Abstract

A sensitive reversed-phase high-performance liquid chromatographic method has been developed and validated for the quantitative determination of docetaxel (I) in human plasma. The concentrations in plasma, for validation procedures spiked with known amounts of I, are read from calibration curves in the range of 10-20,000 ng/ml. The sample preparation involved a liquid-liquid extraction of 1000 microl of sample with a mixture of acetonitrile-n-butylchloride (1:4, v/v). The related compound paclitaxel (II) was used as internal standard. Chromatographic separations were performed an Inertsil ODS-80A column, with UV detection performed at 230 nm. The overall extraction recoveries were 84.3 and 90.0% for I and II, respectively. The lower limit of quantitation was 10 ng/ml, and the accuracy, within-run and between-run precisions at three tested concentrations fell within the generally accepted criteria for bioanalytical assays.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9210450     DOI: 10.1016/s0378-4347(97)00089-3

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Sci Appl        ISSN: 1387-2273


  15 in total

Review 1.  Clinical pharmacokinetics of docetaxel.

Authors:  S J Clarke; L P Rivory
Journal:  Clin Pharmacokinet       Date:  1999-02       Impact factor: 6.447

Review 2.  Clinical pharmacokinetics of docetaxel : recent developments.

Authors:  Sharyn D Baker; Alex Sparreboom; Jaap Verweij
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

3.  4β-hydroxycholesterol as an endogenous CYP3A marker in cancer patients treated with taxanes.

Authors:  Anne-Joy M de Graan; Alex Sparreboom; Peter de Bruijn; Evert de Jonge; Bronno van der Holt; Erik A C Wiemer; Jaap Verweij; Ron H J Mathijssen; Ron H N van Schaik
Journal:  Br J Clin Pharmacol       Date:  2015-08-12       Impact factor: 4.335

4.  A sensitive docetaxel assay in plasma by solid-phase extraction and high performance liquid chromatography-UV detection: validation and suitability in phase I clinical trial pharmacokinetics.

Authors:  C J Ardiet; B Tranchand; S Zanetta; A Guillot; E Bernard; M Peguy; P Rebattu; J P Droz
Journal:  Invest New Drugs       Date:  1999       Impact factor: 3.850

5.  Nanostructured Cubosomes in a Thermoresponsive Depot System: An Alternative Approach for the Controlled Delivery of Docetaxel.

Authors:  Nilesh R Rarokar; Suprit D Saoji; Nishikant A Raut; Jayashree B Taksande; Pramod B Khedekar; Vivek S Dave
Journal:  AAPS PharmSciTech       Date:  2015-07-25       Impact factor: 3.246

6.  Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients.

Authors:  Sin Chi Chew; Edwin Sandanaraj; Onkar Singh; Xiangai Chen; Eng Huat Tan; Wan Teck Lim; Edmund J D Lee; Balram Chowbay
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

7.  Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients.

Authors:  Sin-Chi Chew; Joanne Lim; Onkar Singh; Xiangai Chen; Eng-Huat Tan; Edmund-J D Lee; Balram Chowbay
Journal:  Eur J Clin Pharmacol       Date:  2013-11-06       Impact factor: 2.953

8.  ABCB1 genetic variation influences the toxicity and clinical outcome of patients with androgen-independent prostate cancer treated with docetaxel.

Authors:  Tristan M Sissung; Caitlin E Baum; John Deeken; Douglas K Price; Jeanny Aragon-Ching; Seth M Steinberg; William Dahut; Alex Sparreboom; William D Figg
Journal:  Clin Cancer Res       Date:  2008-07-15       Impact factor: 12.531

9.  Evaluation of the pharmaceutical quality of docetaxel injection using new stability indicating chromatographic methods for assay and impurities.

Authors:  Annarapu Malleswara Reddy; Nagaraju Banda; Shinde Govind Dagdu; Dama Venugopala Rao; Chandra Sekhar Kocherlakota; Vyas Krishnamurthy
Journal:  Sci Pharm       Date:  2010-03-05

10.  Disposition kinetics of taxanes in peritoneal dissemination.

Authors:  Ken'ichi Miyamoto; Tsutomu Shimada; Kazuki Sawamoto; Yoshimichi Sai; Yutaka Yonemura
Journal:  Gastroenterol Res Pract       Date:  2012-05-16       Impact factor: 2.260

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.